FDA Warning Letters: Nov. 18 And 25
This article was originally published in The Gray Sheet
Executive Summary
One of the four device-focused warning letters posted by FDA in the past two weeks targets Quality System Regulation violations at two separate facilities of peripherally inserted central catheter maker Navilyst Medical, part of AngioDynamics.